Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

Overview of attention for article published in Arthritis Research & Therapy, June 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 61 Dimensions

Readers on

mendeley: 83 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors

Grant US-8835435-B2

United States of America

TREATMENT OF RHEUMATOID ARTHRITIS WITH MASITINIB

Application WO-2011151372-A1

World Intellectual Property Organisation (WIPO)

TREATMENT OF GIST WITH MASITINIB

Application WO-2011092273-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.